Centocor launches corporate blog

Share this article:
Katz: leading Centocor into blogosphere
Katz: leading Centocor into blogosphere

Centocor launched itself into the blogosphere with the debut of its corporate blog at cnto411.com.

Centocor spokeswoman Melissa Katz told MM&M the corporate blog aims to serve as a forum for discussion on issues relevant to the industry and not a platform for sounding off on Centocor products.
 
“I plan on posting to the blog as often as I can on issues that are relevant, hopefully a couple of times a week,” Katz said. Michael Parks, VP of corporate comms and executive producer of Centocor's unbranded feature length film Innerstate, will serve in the role the blog's guest author.

“Around the time of Innerstate's debut about a year ago, we realized that we weren't paying enough attention to the blogosphere,” Katz said. “Since then we have been working with those bloggers to see how we can better communicate with them.”

Centocor, joins its parent company Johnson & Johnson which began corporate blogging with jnjbtw.com last summer. J&J's blog, edited by spokesman Marc Monseau, has taken a similar tack as a forum for discussion of non-product specific, industry related issues.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in News

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.